Intelligence ยท Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors โ phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 18,156
- Companies
- 1,062
- Drugs tracked
- 3,385
Quick answer
NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text โ searchable for business development and competitive intelligence.
-
Tetravalent influenza vaccine developed by Sinovac Biotech Co.
SINOVAC BIOTECH LTD
Influenza
1 trial -
Three doses of experimental sIPV of lot 1 at the schedule of 2,3,4 months of age
SINOVAC BIOTECH LTD
Poliomyelitis
1 trial -
Trivalent COVID-19 Vaccine (Vero Cell), Inactivated, Prototype Strain, Delta Strain and Omicron Strain
SINOVAC BIOTECH LTD
COVID-19
1 trial -
Two doses of commercial scale inactivated SARS-CoV-2 vaccine at the schedule of day 0,14
SINOVAC BIOTECH LTD
Covid19
1 trial -
Vaccine manufactured at commercialized scale
SINOVAC BIOTECH LTD
Varicella
1 trial -
Varicella Vaccine
SINOVAC BIOTECH LTD
Varicella
1 trial -
Varicella Vaccine
SINOVAC BIOTECH LTD
Varicella (Chickenpox)
1 trial -
bivalent enterovirus vaccine (Vero cell), inactivated
SINOVAC BIOTECH LTD
Hand, Foot, and Mouth Disease๏ผHFMD)
1 trial -
experimental vaccine
SINOVAC BIOTECH LTD
Epidemic Meningitis
4 trials -
sIPV-bOPV-bOPV vaccination schedule
SINOVAC BIOTECH LTD
Poliomyelitis
1 trial -
sIPV-sIPV-bOPV vaccination schedule
SINOVAC BIOTECH LTD
Poliomyelitis
1 trial -
three consecutive lots of EV71 vaccine
SINOVAC BIOTECH LTD
Hand, Foot and Mouth Disease
1 trial -
100U EV71 vaccine with adjuvant
SINOVAC BIOTECH LTD
Infection, Viral, Enterovirus
1 trial -
400 U EV71 vaccine with adjuvant
SINOVAC BIOTECH LTD
Infection, Viral, Enterovirus
1 trial -
COVID-19 Vaccine (Vero Cell), Inactivated (Medium-dose)
SINOVAC BIOTECH LTD
COVID-19
1 trial -
COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain
SINOVAC BIOTECH LTD
COVID-19
1 trial -
CoronaVacยฎ
SINOVAC BIOTECH LTD
COVID-19
1 trial -
Low-dose experimental vaccine
SINOVAC BIOTECH LTD
Herpes Zoster
1 trial -
Low-dose of tetravalent inactivated enterovirus vaccine (Vero cell)
SINOVAC BIOTECH LTD
Hand, Foot, and Mouth Disease (HFMD)
1 trial -
Medium-dose COVID-19 Vaccine(Vero Cell),Inactivated
SINOVAC BIOTECH LTD
COVID-19
1 trial -
Oral hexavalent reassortant rotavirus attenuated live vaccine
SINOVAC BIOTECH LTD
Rotavirus Gastroenteritis
2 trials -
SA55 Injection
SINOVAC BIOTECH LTD
Infection of Upper Respiratory Tract Caused by 2019-nCoV
1 trial -
SNA02-48
SINOVAC BIOTECH LTD
Tetanus
1 trial -
Single-dose regimen of high dosage investigational sIPV
SINOVAC BIOTECH LTD
Poliomyelitis
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1โ3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync โ verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources